MONOCLONAL ANTIBODY 88BV59, SUBCLONES AND METHOD OF MAKING

This invention relates to monoclonal antibody 88BV59 produced by B-cell lines derived from B-cells of cancer patients actively immunized with autologous tumor antigen. These monoclonal antibodies can be used in both diagnostic procedures and therapy for human cancers. L'invention concerne l...

Full description

Saved in:
Bibliographic Details
Main Authors KOBRIN, BARRY, J, HASPEL, MARTIN, V, FRALEY, MARIE, ELENA, A, HANNA, MICHAEL, G, HOOVER, HERBERT, C
Format Patent
LanguageEnglish
French
Published 10.08.1995
Edition6
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:This invention relates to monoclonal antibody 88BV59 produced by B-cell lines derived from B-cells of cancer patients actively immunized with autologous tumor antigen. These monoclonal antibodies can be used in both diagnostic procedures and therapy for human cancers. L'invention concerne l'anticorps monoclonal 88BV59 produit par des lignées de cellules B dérivées de cellules B de patients atteints d'un cancer immunisés activement avec un antigène tumoral autologue. Ces anticorps monoclonaux peuvent être utilisés à la fois dans des procédures de diagnostics et en thérapie pour traiter des cancers chez l'homme.
Bibliography:Application Number: WO1995US01440